Shree Ganesh Bio-Tech (India) Other Announcement
Company submitted its quarterly shareholding pattern under SEBI Regulation 31(1)(b) for the quarter ended September 2026.
ALFA Filings
Every announcement, straight from the exchange
Every Shree Ganesh Bio-Tech (India) other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements
Company submitted its quarterly shareholding pattern under SEBI Regulation 31(1)(b) for the quarter ended September 2026.
Shree Ganesh Biotech (India) Limited has updated its official website address to www.shreeganeshbiotech.bar. Exchanges are requested to update their records accordingly.
Shree Ganesh Biotech (India) Limited has declared that it has no unutilised funds from any prior public issues, rights issues, or preferential placements as of June 2026.
Shree Ganesh Biotech (India) Limited submitted its Annual Secretarial Compliance Report for the financial year 2025-26. The report confirms adherence to SEBI regulations and listing requirements.